Clinical Trial Update: The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of DWP16001 versus an active comparator in adults with Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED